Valink Therapeutics
Focus: Valink Therapeutics is a Boston-based biotech company specializing in bispecific antibodies for neurology applications. The company is in early-stage development with limited public disclosure of scale and funding details.
Profile data last refreshed 8h ago · AI intelligence enriched 2w ago
Open Jobs
1+1 this month
Stable — net +1 jobs in 30d
2 added, 1 removed. Backfill posture.
Should You Work at Valink Therapeutics?
AI assessmentValink represents a specialized, science-driven bet on bispecific antibodies, but early pipeline stage and thin hiring velocity make it suitable only for platform-focused scientists with tolerance for pre-clinical risk.
Why Work Here
- Perfect H1B sponsorship record (9 approvals, 0 denials in 2023) signals stable visa support and hiring confidence.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Open Jobs (1)
Interview Prep Quick Facts
Help build intelligence for Valink Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.